These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 24681001)

  • 1. Th17 cells in central nervous system autoimmunity.
    Sie C; Korn T; Mitsdoerffer M
    Exp Neurol; 2014 Dec; 262 Pt A():18-27. PubMed ID: 24681001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
    Luchtman DW; Ellwardt E; Larochelle C; Zipp F
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):403-13. PubMed ID: 25153998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
    Lowther DE; Chong DL; Ascough S; Ettorre A; Ingram RJ; Boyton RJ; Altmann DM
    Acta Neuropathol; 2013 Oct; 126(4):501-15. PubMed ID: 23934116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deleterious versus protective autoimmunity in multiple sclerosis.
    Kostic M; Stojanovic I; Marjanovic G; Zivkovic N; Cvetanovic A
    Cell Immunol; 2015 Aug; 296(2):122-32. PubMed ID: 25944389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERβ-Dependent Direct Suppression of Human and Murine Th17 Cells and Treatment of Established Central Nervous System Autoimmunity by a Neurosteroid.
    Aggelakopoulou M; Kourepini E; Paschalidis N; Simoes DC; Kalavrizioti D; Dimisianos N; Papathanasopoulos P; Mouzaki A; Panoutsakopoulou V
    J Immunol; 2016 Oct; 197(7):2598-609. PubMed ID: 27549171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MiRNAs: new actors in the physiopathology of multiple sclerosis].
    Jagot F; Davoust N
    Med Sci (Paris); 2017; 33(6-7):620-628. PubMed ID: 28990564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th9 cells in the pathogenesis of EAE and multiple sclerosis.
    Elyaman W; Khoury SJ
    Semin Immunopathol; 2017 Jan; 39(1):79-87. PubMed ID: 27844107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation and regulation of CNS autoimmunity.
    Goverman J; Brabb T; Paez A; Harrington C; von Dassow P
    Crit Rev Immunol; 1997; 17(5-6):469-80. PubMed ID: 9419434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung inflammation stalls Th17-cell migration en route to the central nervous system during the development of experimental autoimmune encephalomyelitis.
    Kanayama M; Danzaki K; He YW; Shinohara ML
    Int Immunol; 2016 Sep; 28(9):463-9. PubMed ID: 26989091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Sosa RA; Forsthuber TG
    J Interferon Cytokine Res; 2011 Oct; 31(10):753-68. PubMed ID: 21919736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
    Mc Guire C; Prinz M; Beyaert R; van Loo G
    Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell trafficking in the central nervous system.
    Sallusto F; Impellizzieri D; Basso C; Laroni A; Uccelli A; Lanzavecchia A; Engelhardt B
    Immunol Rev; 2012 Jul; 248(1):216-27. PubMed ID: 22725964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
    Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
    J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.